Kybella
Kybella™ is the first FDA-approved injectable drug that targets submental fullness, often referred to as a “double chin”. Bellaire Dermatology, in Houston, Texas was one of the first practices to offer this revolutionary treatment to solve an issue that bothers 68% of consumers. As one of the first providers to offer the Kybella™ treatment, our physicians are highly trained in patient assessment and administration of Kybella™ for optimal results. A treatment plan will be tailored to each patient to achieve the desired improvement in submental fullness.
